Enhanced Quality in Primary Care for Elders with Diabetes and Dementia (EQUIPED-ADRD)
提高患有糖尿病和痴呆症的老年人的初级保健质量 (EQUIPED-ADRD)
基本信息
- 批准号:10163761
- 负责人:
- 金额:$ 79.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-30 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse eventAffectAgeAlzheimer&aposs disease related dementiaAmericanBlood PressureCardiovascular DiseasesCaregiver BurdenCaregiversCaringChronicChronic DiseaseClinicClinicalClinical TrialsComplexComputerized Medical RecordConfusionConsensusDataDecision MakingDementiaDevelopmentDiabetes MellitusDiagnosisDiseaseElderlyElectronic Health RecordEthnic OriginEvaluation MethodologyFamilyFamily CaregiverFeedbackFriendsGoalsGuidelinesHealth PrioritiesHealth StatusHealth systemHealthcare SystemsHeterogeneityHospitalsHypertensionHypoglycemiaImpaired cognitionInterventionInterviewLeadLearningLife ExpectancyLinkLogisticsLong-Term Care for ElderlyMedicalMedicare/MedicaidMethodsMicrovascular DysfunctionOutcomePatientsPhasePhased Innovation AwardsPrevalencePrimary Health CareProcessProviderQuality of CareQuality of lifeRaceRandomizedRandomized Controlled TrialsReportingResearchResourcesRiskSelf ManagementSeveritiesSiteStressSurveysSymptomsSystemTestingUncertaintyacute carebaseblood pressure regulationcare providersclinical practicecomorbiditycostdesigndiabetes managementdiabeticdiabetic patientelectronic datafeasibility testinghealth care servicehospital utilizationimprovedinsurance claimsmedical complicationmedical specialtiesolder patientpaymentpragmatic trialpreferenceprogramsskillstrial design
项目摘要
Over 11 million Americans who are ≥65 years have Diabetes (DM), a prototypic chronic disease requiring self-management.
Up to 30% of older adults have co-occurring DM and Alzheimer’s disease and related dementia
(ADRD) and older people with DM may have as much as a two-fold risk of developing ADRD. Caregivers of
patients with co-occurring DM-ADRD have many unmet needs, adversely affecting caregivers’ ability to
manage these conditions. Moreover, a lack evidence for what constitutes optimal DM management for these
patients, particularly those of more advanced age (≥ 75 years), further compounds the challenge of managing
this chronic and often comorbid disease from both the patient and medical provider perspective. With a lack of
decisional guidance, primary care providers are currently ill equipped to direct care to achieve best outcomes.
The goal of this research is to develop and test a quality improvement program for older patients with DMADRD,
using a pragmatic randomized controlled trial (RCT) and mixed methods in a large, diverse healthcare
system. This will feature consensus decisional guidance for the medical management of DM-ADRD patients,
PCP workflow enhancements including use of a panel manager and the electronic health record (EHR) for
decision support/feedback, and PCP collaborative learning. To conduct this study, “Enhanced Quality In
Primary care for Elders with Diabetes-ADRD” (EQUIPED-ADRD), we will use the R21/R33 mechanism. The
R21 in the first year will develop key resources needed for the pragmatic trial, such as provider decisional
guidance based on current evidence, trial design and evaluation methodology, appropriate healthcare system
administrative / EHR support, and will test intervention feasibility. The R33 will implement the larger pragmatic
trial in a large healthcare system through cluster randomization of the 12 largest primary care practice sites
with ~60 providers and over 600 patients with diagnosed DM and ADRD. It will test hypotheses about whether
care based on explicit standards for DM medical management for people with ADRD will: H1) Improve patient
symptoms and quality of life while maintaining expected clinical outcomes; H2) decrease patient and caregiver
management burden and improve care quality based on patient/caregiver preferences; H3) (secondary)
decrease specialty, ED and hospital utilization. We will gather data from the EHR, Medicare and Medicaid
insurance claims, caregiver surveys and qualitative interviews, and clinician interviews.
If this clinical trial demonstrates that patients and family caregivers who receive this enhanced care quality
program achieve established goals for diabetic care in addition to fewer dementia-related symptoms, less
caregiver burden and stress, and fewer DM-related adverse events, potentially avoidable and costly utilization
may also decrease. This best practice approach could then be widely disseminated to other clinical practices.
超过1100万65岁以上的美国人患有糖尿病(DM),这是一种需要自我管理的典型慢性疾病。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Barriers to Vaccination Among People with Parkinson's Disease and Implications for COVID-19.
- DOI:10.3233/jpd-202497
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Phanhdone T;Drummond P;Meisel T;Friede N;Di Rocco A;Chodosh J;Fleisher J
- 通讯作者:Fleisher J
Perceptions of Treatment Burden Among Caregivers of Elders With Diabetes and Co-morbid Alzheimer's Disease and Related Dementias: A Qualitative Study.
患有糖尿病和共病阿尔茨海默病及相关痴呆症的老年人的护理人员对治疗负担的看法:一项定性研究。
- DOI:10.1177/10547738211067880
- 发表时间:2023
- 期刊:
- 影响因子:1.7
- 作者:VaughanDickson,Victoria;Melnyk,Halia;Ferris,Rosie;Leon,Alejandra;Arcila-Mesa,Mauricio;Rapozo,Crystalinda;Chodosh,Joshua;Blaum,CarolineS
- 通讯作者:Blaum,CarolineS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSHUA CHODOSH其他文献
JOSHUA CHODOSH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSHUA CHODOSH', 18)}}的其他基金
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
退伍军人管理局急诊科的听力障碍、策略和结果
- 批准号:
10450700 - 财政年份:2018
- 资助金额:
$ 79.7万 - 项目类别:
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
退伍军人管理局急诊科的听力障碍、策略和结果
- 批准号:
9927923 - 财政年份:2018
- 资助金额:
$ 79.7万 - 项目类别:
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
退伍军人管理局急诊科的听力障碍、策略和结果
- 批准号:
10660951 - 财政年份:2018
- 资助金额:
$ 79.7万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 79.7万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 79.7万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 79.7万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 79.7万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 79.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 79.7万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 79.7万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 79.7万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 79.7万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 79.7万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




